Biomedicalization: The Expanding Reach of Biomedicine into Life & Society

Biomedicalization — the process by which biomedical science, technology, and logic extend beyond clinical medicine into diverse domains of life, redefining normalcy, identity, and social structures. Coined by sociologists (Clarke et al., 2003) as the successor to medicalization.

From Medicalization to Biomedicalization

Medicalization (1970s–90s)Biomedicalization (1990s–present)
Deviance → illness (e.g., homosexuality, menopause)Risk → pre-disease (pre-diabetes, pre-hypertension, osteopenia)
Physician authority centralDistributed: patients, biotech, pharma, data, algorithms
Treatment of diagnosed diseaseEnhancement, optimization, prevention, surveillance
Pharmaceuticals as primary toolGenomics, proteomics, digital health, AI, neuromodulation
Individual bodyMolecular body, data body, networked body

Five Key Drivers

  1. Molecularization: Disease redefined at genetic/molecular level (biomarkers, SNPs, liquid biopsy).
  2. Technoscientific Innovation: CRISPR, CAR-T, organoids, wearables, continuous monitoring, digital twins.
  3. Pharmaceuticalization: Drugs for risk reduction (statins, PrEP), enhancement (cognitive, cosmetic), lifestyle (weight loss, sleep).
  4. Patient as Consumer/Entrepreneur: Direct-to-consumer testing (23andMe), self-tracking, biohacking, medical tourism.
  5. Surveillance & Governance: Population screening, newborn genomics, health data analytics, algorithmic triage.

Manifestations

  • Reproductive: IVF, PGT, NIPT, surrogacy, egg freezing, mitochondrial replacement.
  • Neuro: ADHD diagnosis surge, cognitive enhancers, neuromodulation (TMS, DBS), digital phenotyping.
  • Aging: Anti-aging medicine, senolytics, biomarker clocks, longevity clinics.
  • Mental Health: DSM expansion, pharmacogenomics, digital therapeutics, psychedelic-assisted therapy.
  • Identity: Genetic ancestry, microbiome profiling, polygenic risk scores shaping life choices.

Critical Implications

  • Equity: Access gaps — genomic medicine, expensive biologics, digital divide.
  • Overscreening/Overdiagnosis: Incidentalomas, indolent cancers, risk factor inflation.
  • Genetic Discrimination: GINA protections incomplete (life, disability, long-term care insurance).
  • Privacy: Genomic data, wearable streams, EHR secondary use.
  • Responsibilization: Health as personal project; structural determinants obscured.

Conclusion

Biomedicalization transforms what counts as health, who defines it, and how it is pursued. It offers unprecedented intervention capacity but demands vigilant ethical, regulatory, and social scrutiny to ensure it serves human flourishing, not just biomedical expansion.

Healthcare Management - Related Articles